Roger G. Harrison, Ph.D.  -  Philadelphia

Dr. Harrison has over 30 years of experience in the pharmaceutical industry.  He received a Ph.D. in Organic Chemistry from the University of Leeds, in England in 1971 and then conducted postdoctoral research at the University of Zurich in Switzerland.  He joined Eli Lilly and Company in the United Kingdom in 1972 as a medicinal research scientist, subsequently transitioning into management, where he became responsible for research, product development, and regulatory affairs.  In 1984 he moved to the headquarters of Lilly in Indianapolis, and remained with the company until early 2001.  Some of the assignments held by Dr. Harrison in the United States were head of pharmaceutical research, director of organic and physical chemistry research, director of biochemistry research, director of infectious disease research, director of formulation development and technology planning, director of development projects management, global product team leader, and director of alliance management. 

Dr. Harrison became CEO and President, and member of the board, of Antares Pharma, a publicly traded specialty pharmaceutical company in 2001, and led the company through development of successful partnering programs and fund raising before leaving in September 2004.  He has numerous publications and patents in diverse fields and has co-authored four books. He is recognized as knowledgeable in most areas of pharmaceutical research, product development, regulatory affairs, and development of medical devices.

Dr. Harrison is the non-executive Chairman of Advanced Respiratory Technologies, Inc.; a Board member and Chair of the Scientific Advisory Committee of Performance Health Technologies; and a Board member of Macromed Inc.  He is also a member of the editorial council for Specialty Pharma, a journal whose first edition will be published in March, 2005.

Tel:  +1-610-321-0194

Email:  roger_harrison@plexusventures.com